Development of new indicators for the launch of a Japanese version of the NIH (5) : Analysis based on refined indicators for patents linked with marketed drugs and pipelines

  • JIBU Mari
    The Organisation for Economic Co-operation and Development (OECD) Japan Science and Technology Agency (JST) Institute for Technology, Enterprise and Competitiveness, Doshisha University
  • OSABE Yoshiyuki
    The Organisation for Economic Co-operation and Development (OECD) Japan Patent Office

Bibliographic Information

Other Title
  • 日本版NIH創設に向けた新しい指標の開発(5) パイプラインにつながる特許判別指標の応用
  • ニホンバン NIH ソウセツ ニ ムケタ アタラシイ シヒョウ ノ カイハツ(5)パイプライン ニ ツナガル トッキョ ハンベツ シヒョウ ノ オウヨウ

Search this article

Abstract

For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried to give an overview and future prospects of pharmaceutical industry based on new indicators. Here we show the trends of very basic research of small molecule drug and bio-medicine by country, patents assignees, using new indicators for identifying patents related with pharmaceutical entities' marketed drugs and pipelines.

Journal

Citations (4)*help

See more

References(4)*help

See more

Details 詳細情報について

Report a problem

Back to top